The AR/ARD1/DLGAP5 Axis Drives Oncogenesis and Immune Evasion via PD-L1 Upregulation in Androgen Receptor-Positive Triple-Negative Breast Cancer.
Triple-negative breast cancer (TNBC) poses a significant clinical challenge due to its aggressive nature and lack of targeted therapies. A subset expressing the Androgen Receptor (AR) offers a therapeutic opportunity, yet the mechanisms remain incompletely understood. Breast cells were cultured under hormone-deprived o...